Skip to content
2000
Volume 3, Issue 2
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

The past decade has been marked by significant advances in the application of gene transfer into living cells of animals and humans, with the resulting catapulting of preclinical and basic scientific concepts into therapeutic trials. A variety of virus-mediated gene delivery techniques have proved to be superior to other methodologies. This article concisely reviews the current status of gene and tumor therapy, focusing on virus-based technologies, describes the molecular biology of neurotropic herpesviruses and the application of herpes simplex virus, a relative of pseudorabies virus (PRV) in gene transfer and cancer therapy protocols. Finally, it addresses the issue of whether PRV, a nonhuman pathogen, could serve as a suitable research and therapeutic tool as concerns genetic and tumor therapy.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/1566523034578393
2003-04-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/1566523034578393
Loading

  • Article Type:
    Review Article
Keyword(s): cancer; gene therapy; gene transfer; herpes; hsv; pseudorabies virus; tumor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test